| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Disc Medicine Inc. | MWTX-003 - (DISC-3405) | Polycythemia vera (PV) | Phase 2 | Ongoing | Intravenous | Hematology |
| Disc Medicine Inc. | GEM103 (ReGAtta) | Dry Age-related Macular Degeneration / Geographic Atrophy | Phase 2a | Trial Discontinued | Intravitreal injection | Opthalmic |
| Disc Medicine Inc. | GEM103 (ReGAtta) | Dry Age-related Macular Degeneration / Geographic Atrophy | Phase 2a | Trial Discontinued | Intravitreal injection | Opthalmic |
| DMK Pharmaceuticals Corp Com Par $0.001 | APC-1000 | Asthma/COPD | Phase 2 | Inhalation | Respiratory | |
| DMK Pharmaceuticals Corp Com Par $0.001 | APC-8000 (sublingual tadalafil) | Erectile dysfunction | NDA Filing | Sublingual | N/A | |
| DMK Pharmaceuticals Corp Com Par $0.001 | APC-1000 | Asthma/COPD | Phase 2 | Inhalation | Respiratory | |
| DMK Pharmaceuticals Corp Com Par $0.001 | Tempol | COVID-19 | Phase 2/3 | Oral | COVID-19 | |
| DMK Pharmaceuticals Corp Com Par $0.001 | APC-410 (tempol) - (Topical Gel) | Radiation Dermatitis | Phase 2 | Topical | Wound Care |